New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
10:02 EDTOMC, NERV, GLRE, DG, NEP, ISTR, FSRV, SSE, NYLD, IPG, ESRTOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Dollar General (DG) initiated with a Hold at Argus... Empire State Realty (ESRT) initiated with a Market Perform at Wells Fargo... FirstService (FSRV) initiated with an Outperform at RBC Capital... Greenlight Capital (GLRE) initiated with an Outperform at Keefe Bruyette... Interpublic Group (IPG) initiated with a Neutral at Citigroup... Investar Holding (ISTR) initiated with a Buy at Sterne Agee... Minerva (NERV) initiated with an Outperform at RW Baird... NRG Yield (NYLD) reinstated with a Buy at Deutsche Bank... NextEra Energy Partners (NEP) initiated with an Overweight at Barclays... Omnicom (OMC) initiated with a Sell at Citigroup... Seventy Seven Energy (SSE) initiated with a Neutral at Susquehanna.
News For DG;ESRT;FSRV;GLRE;IPG;ISTR;NERV;NYLD;NEP;OMC;SSE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 3, 2016
11:26 EDTDGOptions with increasing call volume; LOW LNC DG EW SNOW KLIC CIT AN EAT SYT
Subscribe for More Information
February 1, 2016
08:34 EDTNERVMinerva announces results from Phase I clinical trial with MIN-202
Subscribe for More Information
January 29, 2016
10:05 EDTNYLDOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: American Equity (AEL) initiated with an Outperform at RBC Capital... Calpine (CPN) initiated with a Buy at Guggenheim... Diamondback Energy (FANG) initiated with an Outperform at BMO Capital... Dynegy (DYN) initiated with a Neutral at Guggenheim... ICF International (ICFI) initiated with a Market Perform at Barrington... Juno Therapeutics (JUNO) initiated with a Buy at SunTrust... Kite Pharma (KITE) initiated with a Buy at SunTrust... Match Group (MTCH) initiated with a Neutral at Susquehanna... Medifast (MED) initiated with a Hold at Wunderlich... NRG Energy (NRG) initiated with a Buy at Guggenheim... NRG Yield (NYLD) initiated with a Neutral at Guggenheim... Nutrisystem (NTRI) initiated with a Buy at Wunderlich... Parsley Energy (PE) initiated with an Outperform at BMO Capital... Precision Drilling (PDS) initiated with a Hold at Canaccord... RSP Permian (RSPP) initiated with an Outperform at BMO Capital... Taylor Morrison (TMHC) initiated with a Neutral at Citi... Tortoise North American Energy (TYN) initiated with a Neutral at Guggenheim... WisdomTree (WETF) initiated with a Neutral at Northcoast.
January 28, 2016
17:07 EDTNYLDNRG Yield initiated with a Neutral at Guggenheim
Subscribe for More Information
07:57 EDTNEPNextEra Energy Partners sees annual distribution rate of $1.38-$1.41 by end 2016
Subscribe for More Information
07:55 EDTNEPNextEra Energy Partners reports Q4 net income $5M
NextEra Energy Partners reported Q4 net income attributable to NextEra Energy Partners of $5M. NextEra Energy Partners also reported Q4 adjusted EBITDA of $135M. Q4 cash available for distribution was $75M.
06:24 EDTISTRInvestar Holding reports Q4 core EPS 21c, consensus 27c
Subscribe for More Information
January 27, 2016
08:29 EDTOMCSL Green renews Omnicom at 220 East 42nd Street
Subscribe for More Information
January 25, 2016
13:37 EDTOMCEarnings Watch: Stifel bullish on Procter & Gamble ahead of Q2 earnings report
Procter & Gamble (PG), a consumer packaged goods company, is scheduled to report second quarter earnings before the market open on Tuesday, January 26, with a conference call scheduled for 8:30 a.m. ET. EXPECTATIONS: Analysts are looking for earnings per share of 98c on revenue of $16.94B. The consensus range for EPS is 93c-$1.05 on revenue of $16.44B-$17.4B, according to First Call. LAST QUARTER: Procter & Gamble reported first quarter core EPS of 98c on revenue of $16.53B, compared to analyst estimates of 95c and $17.17B, respectively. The company said that organic sales decreased 1% and that operating cash flow for the quarter was $3.5B. On its Q1 earnings conference call, the company said it expects top line growth to resume in Q2, with further strengthening in the back half of the quarter. Procter & Gamble also said that it had a "good start" to Q2, with October-to-date organic sales growth at the time of 3%. NEWS: On November 18, Procter & Gamble repeated its fiscal 2016 guidance in slides that were presented at the Morgan Stanley Global consumer and Retail Conference. The company backed its FY16 core EPS growth view of down slightly to up mid single digits. At the same conference, the company said it was "not averse" to looking at any option that creates value for stakeholders. On December 7, the Wall Street Journal reported that P&G was moving the lion's share of its media-buying and planning account in North America to Omnicom (OMC) Media Group. A week and a half later, Procter & Gamble, through its subsidiary Gillette, filed a patent infringement lawsuit against Dollar Shave Club alleging that the discount shaving products company violated Gillette's intellectual property by selling infringing razors. On December 29, the Wall Street Journal reported that the consumer packaged goods company was discontinuing a sixth of its Olay products, reducing the Olay product line to roughly 120 products. On January 12, Coty (COTY) confirmed that ten P&G fragrance licenses will transfer to Coty upon regulatory approval and completion of the merger transaction, including Hugo Boss, Gucci, Lacoste, Bruno Banani, Escada, Mexx, James Bond, Gabriela Sabatini, Stella McCartney, and Alexander McQueen. STREET RESEARCH: On January 19, Stifel upgraded Procter & Gamble to Buy from Hold with an $85 price target on shares, saying that it expects the company's sales and operating profit to accelerate as a result of market share gains and cost savings. Stifel added that it expects the company's multiple to rise as well. PRICE ACTION: Procter & Gamble shares are fractionally higher over the last three months. In afternoon trading ahead of Tuesday's earnings report, shares are down roughly 0.3% to $77.14.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use